Monocyte Distribution Width (MDW) in the General Population of Emergency Department Patients With and Without Bacteremia
NCT05296590
Bacteremia, Bacteremia Sepsis
Detroit, Michigan, United States
View Trial DetailsNCT Number: NCT06665542
The study is a multi-center, prospective, observational clinical study enrolling patients from at least 3 medical centers. Study population will include patients over the age of 18 years.
The study will recruit patients presenting with suspicion of acute infection/sepsis and healthy individuals.
Study main objective is to derive and verify a host response based score to predicte severe outcome.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Observational
Carmel MC, Haifa, Israel
For determining disease severity each enrolled patient will be assigned as either "severe outcome patient" or "non severe outcome patient" according to predefined criteria. (or "healthy").
Participation in the study requires the collection of routine patient data and blood sample. Blood samples will be used for measurements of host biomarkers that predict disease severity. The blood samples will be collected upon enrollment.
In addition, a standardized patient questionnaire inquiring about severity outcomes met up to 28 days after presentation will be conducted by phone call 28 to 42 days post admission.
Enrolled patients will be managed according to the current standard of care per standard institutional procedures. Results of the measured biomarkers will not be revealed to the attending clinician and so will not influence patient management.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Suspected acute infection/sepsis patients
Patients eligible for inclusion are required to fulfill all of the following criteria:
Healthy individuals
Patients eligible for inclusion are required to fulfill all of the following criteria:
Exclusion criteria
Suspected acute infection/sepsis patients
Patients fulfilling the following criteria are not eligible for inclusion in this study:
Patients fulfilling the following criteria are not eligible for inclusion in this study:
Time frame: 3,14 and 28 Days
To derive and verify the diagnostic performance of a host-response tool based on novel biomarkers for predicting disease severity in adult patients, aged 18 years or older, presenting with clinical suspicion of acute infection/sepsis.
MeMed Diagnostics Ltd.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05296590
Bacteremia, Bacteremia Sepsis
Detroit, Michigan, United States
View Trial DetailsNCT04695119
Cardiomyopathies, Cardiovascular Diseases
Dijon, France
View Trial DetailsNCT07735741
Infections, Inflammation
Falls Church, Virginia, United States
View Trial DetailsNCT07716956
Infections, Inflammation
Alexandria, Alexandria Governorate, Egypt
View Trial Details